Evidence map›Paper›PMID 41623681›Full record

ArticleCase reports in ophthalmology

Recurrent Episcleritis Revealing Pulmonary Tuberculosis in an Adolescent: A Case Report and Literature Review.

Ali Taghi, Elham Tourjoman, Aya Alayyoubi, Ahmad Alhamid, Nabhan Alnabhan, Ahmad Zein, Mohammad Atia, Taghreed Touma

Abstract readCase Reports
In one paragraph

Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ali TaghiMinister of Health, Damascus, Syria.
Elham TourjomanFaculty of Medicine, Al Hawash Private University, Homs, Syria.
Aya AlayyoubiDepartment of General Surgery, Al-Razi Hospital, Aleppo, Syria.
Ahmad AlhamidDepartment of Orthopedic Surgery, Al-Razi Hospital, Aleppo, Syria.
Nabhan AlnabhanDepartment of Orthopedic Surgery, Al-Razi Hospital, Aleppo, Syria.
Ahmad ZeinDepartment of Pulmonary Medicine, Aleppo Hospital of Internal Medicine, Aleppo, Syria.
Mohammad AtiaDepartment of Gastroenterology, Red Crescent Hospital, Damascus, Syria.
Taghreed ToumaDepartment of Rheumatology, Aleppo Hospital of Internal Medicine, Aleppo, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tuberculosis (TB) can affect the eye through direct infection or immune mechanisms. While ocular TB most often presents as uveitis or scleritis, episcleritis is an uncommon manifestation and can be mistaken for an idiopathic or autoimmune disease. Case Presentations: A 17-year-old female patient presented at our hospital with recurrent episcleritis. The first two flare-ups were mild and responded well to conservative treatment; therefore, no further investigation was pursued at the time. However, during the third episode, routine baseline workup revealed a mildly elevated erythrocyte sedimentation rate with a normal chest radiograph (CXR). Given recurrence and a presumed immune-mediated process, she received topical steroids and low-dose methotrexate. Weeks later, she began experiencing fever and a persistent cough. On repeat CXR showed new left upper-lobe changes prompting computed tomography that revealed cavitary lesions. Bronchoalveolar lavage confirmed Conclusion: In TB-endemic settings, recurrent episcleritis warrants evaluation for TB before initiating or escalating immunosuppression. New systemic symptoms should prompt repeat chest imaging and microbiologic testing.

Indexed as

Anti-tubercular therapyEpiscleritisMethotrexateNight sweatsOcular tuberculosisPulmonary tuberculosisWeight loss

Identifiers

PMID41623681
PMCPMC12858201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.